An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study

NCT02385383 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-03-11

No results posted yet for this study

Summary

This observational study follows a cohort of patients scheduled for elective hip- or knee surgery but has preoperative anemia and are treated with Intravenous (IV) iron prior to surgery according to a recently introduced standardized treatment protocol at 6 high-volume surgical centres.

Conditions

  • Anemia
  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee

Interventions

DRUG

Iron-III Isomaltoside 1000

Protocol for optimizing preoperative Hb using IV Iron-III Isomaltoside 1000

OTHER

Standard Care

Standard Care in a historical control cohort

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • Gentofte Hospital

    collaborator UNKNOWN
  • Vejle Sygehus

    collaborator UNKNOWN
  • Regionshospitalet Viborg, Skive

    collaborator OTHER
  • Farsø Sygehus

    collaborator UNKNOWN
  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Oeivind Jans, M.D., Ph.D. · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-10-31
Completion
2017-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385383 on ClinicalTrials.gov